Results 151 to 160 of about 1,553,593 (211)

Oligosaccharyltransferase (OST) complex inhibition effectively treats rodent and human prions. [PDF]

PLoS Pathog
Beauchemin KS, Kun J, Groveman B, Williams K, Salerno F, Francomacaro LM, Robison P, Haigh CL, Supattapone S.   +8 more
europepmc   +1 more source

Membrane-anchored PrPSc is the trigger for prion synaptotoxicity. [PDF]

PLoS Pathog
Gatdula JRP, Mercer RCC, Alepuz Guillen JA, Vultaggio JS, Harris DA.   +4 more
europepmc   +1 more source

Cellular prion protein and calcium ions trigger the neurotoxicity of α-synuclein aggregates. [PDF]

Cell Biosci
Bigi A, Conti AC, Napolitano L, Fusco G, De Simone A, Chiti F, Cascella R, Cecchi C.   +7 more
europepmc   +1 more source

A neural stem cell-derived 3D spheroid model that recapitulates prion infection and pathology. [PDF]

Mater Today Bio
Park HJ, Kim H, Byun S, Ryou C.
europepmc   +1 more source

Fyn kinase: a key mechanistic regulator and therapeutic target in tauopathy and neurodegenerative diseases. [PDF]

Transl Neurodegener
Wang H, Fan X, Ping J, Shao Q, Wang C, Wang H, Ji Q, Su M, Qian W.   +8 more
europepmc   +1 more source

Regulated coexpression of PrP from different species in mice impacts the replication and host range properties of prion strains. [PDF]

Proc Natl Acad Sci U S A
DeFranco JP, Bian J, Kim S, Atkinson ZN, Crowell J, Kang HE, Bodrogi HO, Christiansen JR, Díaz-Domínguez CM, Telling GC.   +9 more
europepmc   +1 more source

Refined Transgenic Mouse Models Which Recapitulate the Natural Features of Chronic Wasting Disease With Rapid Prion Disease Onsets. [PDF]

J Infect Dis
DeFranco JP, Kim S, Atkinson ZN, Crowell J, Lei S, Bian J, Telling GC.   +6 more
europepmc   +1 more source

Distinct prion conformers from brain and peripheral tissues of gene-targeted mice produce convergent CWD strain properties. [PDF]

PLoS Pathog
DeFranco JP, Atkinson ZN, Crowell J, Shi X, Kim S, Sun JL, Kane SJ, Telling GC.   +7 more
europepmc   +1 more source

Chemo-omic pipeline enables discovery of prion synaptotoxic pathways and inhibitory drugs. [PDF]

PLoS Pathog
Le NTT, Mercer RCC, Fang C, Sundaravadivelu A, Labadorf AT, Lin W, Kwan J, Blum B, Emili A, Harris DA.   +9 more
europepmc   +1 more source